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OBJECTIVES We sought to evaluate and compare recently suggested parameters of reperfusion after
angioplasty in acute myocardial infarction (AMI) for risk stratification during long-term
follow-up.
BACKGROUND Abnormal myocardial perfusion has a detrimental impact on survival. Several parameters of
reperfusion have been evaluated in controlled study populations for risk stratification.
METHODS In 253 consecutive patients undergoing intervention in AMI on a native coronary vessel,
angiographic myocardial blush grade (MBG), corrected TIMI (thrombolysis in myocardial
infarction) frame count (CTFC) and persistent ST-segment elevation (STE) were deter-
mined to evaluate reperfusion. This was a high-risk population, including referral for
treatment failure at a primary center in 29.2%, failed thrombolysis in 22.1% and cardiogenic
shock in 13.4% of cases.
RESULTS In addition to age, patient referral, LBBB and heart rate on admission, MBG 0 to 1 (odds
ratio [OR] 3.23, p 0.001), CTFC (OR 1.01, p 0.015) and persistent STE2 leads
(OR 3.46, p 0.010) were univariate predictors of mortality during a 22.1 15.6 months
follow-up. Myocardial blush grade 0 to 1 (OR  2.17, p  0.033) and persistent STE (OR
 3.61, p  0.017) persisted as independent predictors of mortality, whereas CTFC failed.
Differences in mortality between reperfusion groups at 30 days remained throughout the
complete follow-up. In sequential Cox models, the predictive power of clinical data alone for
mortality (model chi-squared 55.8) was strengthened by adding MBG (model chi-squared
64.2) and ECG postintervention (model chi-squared 69.2).
CONCLUSIONS Myocardial blush grade 0 to 1 and persistent STE are independent predictors for long-term
mortality after angioplasty in AMI. Corrected TIMI frame count is a less powerful predictor.
Combining both parameters to consider quality of reperfusion in the myocardium at risk and
extent of the infarct zone increases the predictive power. (J Am Coll Cardiol 2003;41:
532–8) © 2003 by the American College of Cardiology Foundation
Early restoration of patency and adequate antegrade reflow
in the infarct-related artery has been the primary objective
of treatment strategies in patients with acute myocardial
infarction (AMI) (1,2). In recent years, there has been
increasing recognition that the objective should be extended
to the achievement of adequate reperfusion on the myocar-
dial tissue level (3–5). A lack of myocardial reperfusion in
spite of restored (Thrombolysis In Myocardial Infarction
[TIMI]-3) flow, the “no-reflow” phenomenon, initially has
been described by myocardial contrast echocardiography
and confirmed by other imaging techniques such as positron
emission tomography (3,6). Impaired myocardial reperfu-
sion after AMI is associated with an increased rate of left
ventricular (LV) dysfunction, complications and impaired
survival (4–8).
Several parameters by which myocardial microcirculation
can be easily and reproducibly assessed have been suggested.
Among them are the angiographic myocardial blush grade
(MBG), the corrected TIMI frame count (CTFC) and the
early persistence of ST-segment elevation (STE) (9–13).
The myocardial blush relates to the contrast opacification of
the myocardial bed subtended by the infarct artery. The
CTFC is a quantitative index of the coronary flow in the
infarct-related artery, and persistent STE appears to reflect
inadequate restoration of perfusion on the myocardial tissue
level. The comparative value of different markers of reper-
fusion easily to be obtained during the acute stage of AMI
in a nonselected high-risk population for prediction of
follow up clinical events has not been evaluated. The present
study was undertaken: 1) to compare CTFC, low MBG and
persistent STE regarding their predictive value for mortality
during long-term follow up in a cohort of high-risk AMI
patients undergoing mechanical reperfusion therapy at a
referral center, and 2) to determine if the prognostic value
for mortality can be improved by a combination of param-
eters of microvascular reperfusion.
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METHODS
Study population. Two hundred fifty-three consecutive
patients with first AMI undergoing mechanical revascular-
ization within 12 h of symptom onset at the University
Clinic Aachen from January 1996 through November 1999
were included in the study. Inclusion criteria were 1) typical
anginal pain lasting 30 min, 2) ST-segment elevation of
0.2 mV in at least two contiguous ECG leads. All patients
were considered regardless of hemodynamic status, infarct
vessel and possible thrombolytic therapy before the inter-
vention. Patients presenting 12 h after onset of symptoms
were considered for PTCA only if they had signs of
recurrent myocardial infarction. Twelve-lead electrocardio-
gram was repeated 1 h after PTCA. On the last coronary
angiogram after revascularization, MBG and CTFC were
determined.
Coronary angiography and angioplasty. Coronary an-
giography was done with a frame rate of 12.5/s. Coronary
angiograms were analyzed off-line (QuantCor, CAAS II,
Siemens, Erlangen, Germany). Acetylsalicylic acid (100 mg
daily) and ticlopidine (250 mg twice daily) were given
during follow up.
Myocardial blush grade (MBG) was graded by a blinded
experienced interventionalist on the final angiogram based
on the visual assessment of contrast opacification of the
myocardial territory subtended by the infarct vessel, as
described previously (9). Myocardial blush grade was de-
fined as follows: 0  no myocardial blush or contrast
density; 1  minimal myocardial blush or contrast density;
2  moderate myocardial blush or contrast density but less
than that obtained during angiography of a contralateral or
ipsilateral noninfarct-related coronary artery; and 3  nor-
mal myocardial blush or contrast density, comparable to that
obtained during angiography of a contralateral or ipsilateral
noninfarct-related coronary artery. Myocardial blush grade
0 and 1 were combined in the results. From multiple
orthogonal projections, the single view was chosen that best
isolated the myocardial infarct zone in question.
The CTFC was determined on the final angiogram to
objectively assess coronary blood flow as a continuous
variable, as described recently (11). In brief, the number of
frames required for dye to reach standardized distal land-
marks was counted and divided by 1.7 for the left anterior
descending artery to obtain the corrected frame count.
Subsequently, the number of frames was multiplied by 30
and divided by 12.5 to report a cine frame count in
accordance with standard methods (11). A CTFC 40 was
used to identify patients with depressed reperfusion, as
opposed to patients with a CTFC 40, as described
previously (11). Intra- and interobserver variability in the
assessment of MBG and CTFC were determined from a
random sample of 30 films scored by Ph.H. and R.H.
Assessment of intraobserver variability demonstrated a
kappa of 0.92 for the MBG and a mean deviation of 0.6 
0.4 frames for the CTFC. Assessment of interobserver
variability demonstrated a kappa of 0.87 for the MBG and
a mean deviation of 0.9  0.5 frames for the CTFC.
Electrocardiogram analysis. Electrocardiograms were
done on admission to hospital (first ECG) and in the
coronary care unit 1 h after primary angioplasty. The STE
was evaluated 0.06 s after the end of the QRS-complex in
the 12-lead ECG. Electrocardiogram leads demonstrating a
STE of more than 0.1 mV after angioplasty were considered
to show persistent STE. The number of ECG leads with
persistent STE was used as a parameter to assess the size of
the myocardial area with failed reperfusion. Persistent STE
in 2 leads on a 12-lead ECG was considered an indicator
for more extensive impairment of reperfusion. In addition,
ECGs done after intervention were classified based on
resolution of STE compared with the baseline ECG. The
categories for classification were normalized, improved or
unchanged, as previously described (14).
Clinical follow-up. Follow-up information on patient sur-
vival was obtained in all 253 patients. Data were obtained by
telephone contact with the patient, with one of his or her
immediate relatives and complemented by information ob-
tained by the patient’s general physician or patient charts
from recurrent hospital admissions. In case neither patient
nor relatives could be contacted and patient’s general phy-
sician did not know about the patient’s outcome, the local
population registries were contacted to obtain information
about the patient’s possible death or current location.
Statistical analysis. Analysis was performed using SAS
V8.2 software (SAS Institute Inc., Cary, North Carolina).
Continuous variables are presented as mean SD and were
compared using Student t test, Wilcoxon test, or ANOVA,
as appropriate. Dichotomous variables were compared using
chi-squared statistics or Fisher’s exact test. Patient survival
was analyzed and Kaplan-Meier curves were constructed.
Differences between survival curves were evaluated using the
log-rank test. Receiver operating characteristics curves were
calculated, which considered MBG alone or MBG divided
by number of ECG leads with persistent STE for prediction
of mortality. Cox proportional hazard regression was used to
determine the independent predictors of mortality. Univar-
iate predictors with p  0.1 were included in the multivar-
iate analysis. Values of p  0.05 were considered to indicate
statistical significance.
Abbreviations and Acronyms
AMI  acute myocardial infarction
CTFC  corrected TIMI frame count
LBBB  left bundle branch block
LV  left ventricular, left ventricle
MBG  myocardial blush grade
PTCA  percutaneous transluminal coronary angioplasty
STE  ST-segment elevation
TIMI  Thrombolysis In Myocardial Infarction
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RESULTS
Patient population. Baseline characteristics of the 253
patients included in the analysis are given in Table 1. The
study cohort consisted of a high-risk group of patients.
Seventy-four patients (29.2%) were referrals from other
centers because of cardiogenic shock, failed thrombolysis or
persistent chest pain after conventional treatment. Thirty-
four patients (13.4%) presented in cardiogenic shock, and
56 patients (22.1%) underwent rescue angioplasty for failed
thrombolysis. In 36 patients (14.2%), placement of an
intra-aortic balloon pump for sustained hypotension was
required.
Interventional procedure and late clinical outcome. In
193 patients (76.3%), stent placement was used to optimize
the interventional result, and in 122 patients, (48.2%)
glycoprotein IIb/IIIa receptor antagonists were adminis-
tered.
Thirty-six patients (14.2%) had died at 30-day follow up,
49 patients (19.4%) at 180-day follow-up and 62 patients
(24.5%) during the total follow-up period (22.1  15.6
months).
Myocardial perfusion status and effect on outcomes. Data
on MBG and CTFC at the end of the interventional
procedure as well as interpretable ECGs on admission could
be obtained in all patients. After the interventional proce-
dure no ECG was available in eight patients because of
death of the patient, and 25 patients were excluded from the
evaluation of STE because of left bundle branch block
(LBBB). Seventy-nine patients had MBG 3, 74 patients
MBG 2 and 100 patients MBG 1. Seventy-one patients had
a CTFC40 and 182 patients a CTFC40. One hundred
forty-nine patients had persistent STE in 2 ECG leads;
71 patients had less extensive persistent STE changes.
Patients who died during long-term follow-up were of
higher age, had more diseased coronary arteries, a higher
heart rate before intervention, more frequent LBBB, a
higher peak creatine kinase level, required more frequently
placement of an intra-aortic balloon pump, had less fre-
quent TIMI flow 3 at baseline, a higher CTFC, a higher
number of ECG leads with persistent STE, more frequent
BG  0 and less frequent BG  3 (Table 1). Considering
the level of ST-segment resolution, mortality for patients
with persistence of STE after angioplasty0.7 of first ECG
was 37% compared with 22% with improved ECG (persis-
tence of STE 0.3 to 0.7) and 18% for patients with
normalized ECG (persistence of STE 0.3) (p  0.037).
Perfusion parameters to predict survival during follow-
up. Coronary CTFC, ECG following intervention and the
MBG category allowed prediction of patient mortality at 30
days and during long-term follow-up. Cumulative survival
curves for the three parameters are displayed in Figure 1.
Log-rank statistics demonstrated highly significant differ-
ences between the groups for each parameter. Differences in
mortality observed at 30-day follow-up between the blush
grade groups persisted at 1-year follow-up and during the
complete follow-up period (Table 2). Further subanalysis
considering patients with persistence of STE in 2 ECG
leads demonstrated mortality during follow-up of 4% for
patients with no ECG lead demonstrating persistent STE
(N  28), 5% for patients with one ECG lead with




(n  191) p
Age (yrs) 63.6  10.8 58.3  11.7 0.002
Chest pain to hospital (h) 4.8  5.7 3.8  4.5 0.336
Door to needle time (h) 2.0  2.2 1.9  2.0 0.892
Female 17 (27%) 31 (16%) 0.082
Cardiogenic shock 11 (18%) 23 (12%) 0.171
Heart rate before PTCA (beats/min) 90.7  26.5 73.3  16.4  0.001
Patient referral 24 (39%) 50 (26%) 0.063
No. of diseased vessels 2.1  0.8 1.7  0.7 0.002
Peak creatine kinase (U/l) 1,492  1,713 914  1,166 0.004
Abciximab 30 (48%) 92 (48%) 1.000
IABP 25 (41%) 11 (6%)  0.001
Stent 42 (68%) 151 (79%) 0.058
Target vessel: left anterior descending 24 (39%) 80 (42%) 0.626
Baseline TIMI flow 3 7 (11%) 67 (35%)  0.001
Previous myocardial infarction 22 (36%) 67 (35%) 1.000
Left bundle branch block 14 (23%) 11 (6%)  0.001
Markers of reperfusion
Postprocedure TIMI flow 3 50 (80%) 173 (91%) 0.064
MBG 0/1 39 (63%) 61 (32%)  0.001
MBG 2 14 (23%) 60 (31%) 0.206
MBG 3 9 (14%) 70 (37%) 0.004
CTFC (frames) 42.6  32.2 32.8  23.9 0.012
ECG leads with ST-segment elevation post PTCA 4.42  1.87 3.20  2.22 0.001
CTFC  corrected TIMI frame count; IABP  intraaortic balloon pump; MBG  myocardial blush grade; PTCA 
percutaneous transluminal coronary angioplasty; TIMI  Thrombolysis In Myocardial Infarction
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persistent STE (n  21) and 14% for patients with two
ECG leads with persistent STE (n  22).
Univariate predictors of cumulative mortality by Cox
proportional hazard regression analysis were age 70 years,
patient referral, heart rate on admission 100 beats/min,
LBBB on admission, CTFC, persistent STE in 2 ECG
leads after PTCA and MBG 0 to 1 (Table 3). In a
multivariate analysis, MBG 0 to 1 and persistent STE in2
ECG leads remained independent determinants of mortal-
ity, in addition to advanced age, patient referral, heart rate
on admission and LBBB (Table 4); CTFC did not have the
power to persist as an independent predictor. Considering
in a multivariate analysis only those 223 patients with TIMI
flow 3 postprocedure, the same variables, including persis-
tent STE in 2 ECG leads and MBG 0 to 1, remained
independent determinants of mortality. Considering level of
ST-segment resolution instead of number of ECG leads
with persistent STE was also a univariate predictor of
mortality (OR  2.95, 95% CI 1.65 to 6.45, p  0.015 for
incomplete resolution compared with normalized ECG).
Sequential Cox hazard models for the prediction of
cumulative mortality were devised to assess the incremental
contribution of MBG and number of ECG leads with
persistent STE to the clinical evaluation of the patient.
Age70 years, patient being a referral, heart rate prior to
intervention and LBBB entered the clinical model (chi-
squared 55.8, p  0.0001). The addition of MBG being 0
to 1 increased the power of the model (chi-squared 64.2, p
 0.0001) and subsequent addition of the number of ECG
leads with persistent STE further increased the power of the
model (chi-squared 69.2, p  0.0001).
The combination of MBG and 1 (number of ECG leads
demonstrating persistent STE after PTCA) had a higher
accuracy to predict mortality than MBG alone (area under
the ROC curve 0.71, 95% CI 0.65 to 0.77 for MBG/
Figure 1. Cumulative survival in 253 patients after mechanical revascularization for acute myocardial infarction stratified by myocardial blush grades (MBG,
left), corrected TIMI frame counts (CTFC, middle) and persistent ST-segment elevation in 2 or 2 electrocardiographic (ECG) leads after PTCA
(percutaneous transluminal coronary angioplasty) (ECG post PTCA, n  220, right). P values represent log-rank for trend. MI  myocardial infarction.






(n  79) p
Death at 30 days 26.0% 9.9% 3.9%  0.001
Death at 1 year 35.1% 13.4% 9.4%  0.001
Death during F/U 39.0% 18.3% 12.4%  0.001
F/U  follow-up; MBG  myocardial blush grade.
Table 3. Univariate Cox Model Predictors of Cumulative
Mortality
OR 95% CI p
Age 70 yrs 2.23 1.20–4.14 0.011
Patient referral 1.77 1.01–3.12 0.047
Heart rate pre PTCA
100 beats/min
4.06 2.11–7.78  0.001
LBBB 3.12 1.51–6.49 0.002
MBG 0–1 vs. MBG 2–3 3.23 1.82–5.88  0.001
ST-segment elevation in
2 leads post PTCA
3.46 1.35–8.86 0.010
CTFC (frame) 1.01 1.00–1.02 0.015
CI  confidence interval; CTFC  corrected TIMI frame count; LBBB  left
bundle branch block; MBG  myocardial blush grade; OR  odds ratio; PTCA 
percutaneous transluminal coronary angioplasty.
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number of ECG leads with persistent STE vs. 0.63, 95% CI
0.57 to 0.70 for MBG alone, p  0.029) (Fig. 2). Patients
with a MBG of 3 and persistent ST-segment elevation in
2 ECG leads had a mortality of 0% at long-term follow-
up. Patients with a MBG of 0, 1 or 2 and persistent STE in
2 ECG leads had a mortality of 13% at long-term follow-
up, whereas patients with a MBG of 0, 1 or 2 and persistent
STE in 2 ECG leads had a mortality of 47% during
long-term follow-up (Fig. 3).
DISCUSSION
This study evaluated and compared simple-to-determine
invasive and noninvasive markers of reperfusion after AMI
regarding their predictive value for mortality. The principle
findings were: 1) myocardial blush score and persistent STE
after coronary intervention are independent predictors of
long-term mortality, 2) a combination of MBG to define
the quality of nonreperfusion and the number of ECG leads
with persistent STE to define the extent of nonreperfusion
allows even improved prediction of mortality during follow
up, 3) CTFC for assessment of coronary blood flow in the
infarct-related artery is less predictive.
Reperfusion after myocardial infarction. Recent studies
have demonstrated that myocardial perfusion and metabo-
lism is often abnormal, despite restoration of TIMI-3 flow
in the infarct-related artery (3–6,8). This “no-reflow” phe-
nomenon is thought to be the result of microvascular
obstruction. It constitutes a marker of more extensive
myocardial tissue damage and is associated with poorer
functional recovery, an increased frequency of congestive
heart failure and adverse outcome (4,5). Thus, inadequate
myocardial reperfusion compromises the potentially benefi-
cial effect of early recanalization of the infarct-related artery.
Several clinically applicable markers of myocardial reperfu-
sion have been proposed. Myocardial blush, the CTFC and
persistent STE are among them. They have in common that
they can be easily determined in clinical practice during the
acute stage of AMI. Myocardial blush, the angiographic
evidence of myocardial perfusion in the myocardial bed
subtended by the infarct artery has been described by van’t
Hof et al. (9). The myocardial blush scale has been found to
relate to the enzymatic infarct size in patients after primary
PTCA for AMI (9,15) and to have a better predictive value
for long-term mortality than Killip class, TIMI grade flow,
LV ejection fraction and other clinical variables. Similarly,
the TIMI frame count at 90 min angiography after throm-
bolytic therapy has been suggested to reflect myocardial
reperfusion and to be an independent predictor of in-
hospital and 1-month clinical outcome (11,16). Early per-
sistence of STE despite a patent infarct artery has also been
shown to be a predictor of higher in-hospital and long-term
mortality (12,13,17). Different parameters to assess persis-
tent STE after revascularization procedures in AMI have
been described. Some of them consider a ratio of preinter-
vention STE to postintervention STE. This has been shown
to be a useful index to assess improvement of reperfusion
after PTCA in the area at risk. However, it yields no
information on the extent of the myocardial area remaining
at risk. The number of ECG leads with persistent STE as
evaluated in this study may allow better assessment of the
area remaining at risk after PTCA in AMI. Recently, TIMI
myocardial perfusion grade and persistence of STE after
intervention have been shown to be associated with infarct
size as assessed by single photon emission computed tomog-
raphy (18). Thus, the mortality differences between the
different perfusion groups are likely to relate to differences in
infarct size.
Prediction of patient outcome. Optimal prediction of LV
function and patient outcome after AMI requires accurate
evaluation of microvascular dysfunction. The optimal pa-
rameter to assess impairment of microvascular function after
AMI should allow an assessment of the extent and quality of
nonreperfusion. Myocardial blush and the number of ECG
leads with persistent STE proved to be independent pre-
dictors of mortality during long-term follow-up. Myocardial
blush grade reflects the quality of reperfusion for a given
perfusion bed. It reflects the microvascular function of a
perfusion bed irrespective of the size of the myocardial
Table 4. Multivariate Cox Model Predictors of Cumulative
Mortality
OR 95% CI p
Age 7 yrs 3.87 2.64–5.66  0.001
Heart rate pre PTCA
100 beats/min
4.68 3.15–6.95  0.001
LBBB 3.36 1.79–6.32 0.013
ST-segment elevation in
2 leads post PTCA
3.61 2.10–6.18 0.017
MBG 0–1 vs MBG 2–3 2.17 1.52–3.23 0.033
Abbreviations as in Table 3.
Figure 2. Receiver operator characteristics (ROC) curves for mortality
during follow up. The ROC curve indicated by the dashed line used only
myocardial blush grade (MBG) analysis, area under the curve  0.63. The
solid line used MBG analysis in combination with number of ECG leads
demonstrating persistent ST-segment elevation, area under the curve 
0.71.
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territory. Thus, MBG is limited by the lack of information
on the size of the endangered perfusion bed. The same
difficulty applies to the CTFC. In addition, the CTFC
determined in the epicardial artery is only an indirect
parameter of the microvascular function of the subtended
perfusion bed. In contrast, the 12-lead ECG yields infor-
mation about the extent of the area at risk.
In this study, a combination of MBG and number of
ECG leads with persistent STE after interventional revas-
cularization was of incremental value for the prediction of
patient outcome. This approach combined an assessment of
the quality of reperfusion by the MBG with an assessment
of the extent of the reperfusion defect using the number of
ECG leads showing persistent STE, thereby increasing the
predictive power of the model.
Several therapeutic strategies have been described to
improve reperfusion in patients with AMI, including me-
chanical protection devices and pharmacological treatment
to specifically improve microvascular function on the myo-
cardial tissue level (19,20). The proposed markers of reper-
fusion may be used as surrogate study end points in clinical
trials (4–11,17) to test the effect of these emerging new
therapeutic strategies. Compared with the standard clinical
end point, mortality, the use of these surrogate end points in
trials analyzing the effect of strategies designed to improve
reperfusion after AMI may allow a reduction of required
patient numbers (4). The choice of the surrogate marker to
be used in future trials has to recognize its predictive
accuracy.
Study limitations. The mortality rate during follow-up
was higher in this study as compared with that in other
recently published studies (21,22). However, in several of
these studies only patients conforming to special inclusion
criteria were part of the analysis, whereas patients with very
high risks were excluded. In contrast, all consecutive pa-
tients with AMI undergoing angioplasty at this referral
center were included in this study, resulting in a study
population with multiple high-risk characteristics. For pa-
tients with normal or intermediate myocardial blush, sur-
vival rates similar to previously reported data were found in
this study (15). Thus, the overall high mortality is likely to
reflect in particular the inclusion of a high rate of patients
with very poor baseline characteristics. The overall mortality
rate as well as the mortality rates for all patient groups
reported in this study may, in fact, better represent those to
be expected in an unselected patient population at a referral
center. Corrected TIMI frame count was no independent
predictor of mortality in this study. It might have become an
independent predictor of mortality in addition to myocar-
dial blush with higher patient numbers, as in a recent study
on 800 patients (23).
This study evaluated patient survival in a retrospective
fashion. Patients were not routinely followed up at pre-
defined time intervals. Rather, patients were contacted only
Figure 3. Cumulative survival in 253 patients after angioplasty for acute myocardial infarction stratified by status of myocardial reperfusion defined by blush
grade and subgrouped by number of electrocardiographic (ECG) leads with persistent ST-segment elevation postangioplasty. MBG  myocardial blush
grade.
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at one time point. However, due to intensive efforts, a
complete follow-up could be obtained regarding patient
mortality. Coronary angiograms were recorded at a speed of
12.5 fps. This might have resulted in minor differences of
the determined CTFC compared with those that would
have been determined with a speed of 30 fps. Finally, the
number of patients included in the analysis was limited
because of confinement of patients’ inclusion to one large
referral center. Larger studies to confirm the results are
required. The limited patient number may have restricted
the ability to demonstrate differences in mortality, myocar-
dial blush and ST resolution between anterior versus inferior
MI and for survival as a function of time to reperfusion
although these associations have been demonstrated in
larger studies.
Conclusions. Myocardial blush and persistent STE after
intervention in AMI are independent predictors of mortal-
ity. A combination of both parameters to consider quality of
reperfusion in the endangered perfusion bed and extent of
the injured myocardium is likely to further increase the
predictive accuracy. Further studies are required to examine
whether they allow superior assessment of mechanical and
pharmacological strategies aiming at the improvement of
myocardial perfusion and clinical outcome of patients with
AMI.
Reprint requests and correspondence: Dr. Rainer Hoffmann,
Medical Clinic I, University RWTH Aachen, Pauwelsstrae 30,
52057 Aachen, Germany. E-mail: RHoffmann@UKAACHEN.de.
REFERENCES
1. The GUSTO Angiographic Investigators. The effects of tissue plas-
minogen activator, streptokinase, or both on coronary-artery patency,
ventricular function, and survival after acute myocardial infarction.
N Engl J Med 1993;329:1615–22.
2. Grines CL, Cox D, Stone GW, et al. A randomized trial of primary
angioplasty compared to heparin-coated stent implantation for acute
myocardial infarction. N Engl J Med 1999;341:1949–56.
3. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion
immediately after successful thrombolysis. A predictor of poor recovery
of left ventricular function in anterior myocardial infarction. Circula-
tion 1992;85:1699–705.
4. Roe MT, Ohman EM, Maas ACP, et al. Shifting the open-artery
hypothesis downstream: the quest for optimal reperfusion. J Am Coll
Cardiol 2001;37:9–18.
5. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no
reflow’ phenomenon. A predictor of complications and left ventricular
remodeling in reperfused anterior wall myocardial infarction. Circula-
tion 1996;93:223–8.
6. Wu KC, Zerhouni EA, Judd R, et al. Prognostic significance of
microvascular obstruction by magnetic resonance imaging in patients
with acute myocardial infarction. Circulation 1998;97:765–72.
7. Suryapranata H, Zijlstra F, MacLeod D, et al. Predictive value of
reactive hyperemic response on reperfusion on recovery of regional
myocardial function after coronary angioplasty in acute myocardial
infarction. Circulation 1994;89:1109–17.
8. Lepper W, Hoffmann R, Kamp O, et al. Assessment of myocardial
reperfusion by intravenous myocardial contrast echocardiography and
coronary flow reserve after primary percutaneous transluminal coronary
angioplasty in patients with acute myocardial infarction. Circulation
2000;101:2368–74.
9. van’t Hof AW, Liem A, Suryapranata H, et al. Angiographic assess-
ment of myocardial reperfusion in patients treated with primary
angioplasty for acute myocardial infarction: myocardial blush grade.
Zwolle Myocardial Infarction Study Group. Circulation 1998;97:
2302–6.
10. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI
myocardial perfusion grade to mortality after administration of throm-
bolytic drugs. Circulation 2000;101:125–30.
11. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a
quantitative method of assessing coronary artery flow. Circulation
1996;93:879–88.
12. Santoro GM, Valenti R, Buonamici P, et al. Relation between ST
segment changes and myocardial perfusion evaluated by myocardial
contrast echocardiography in patients with acute myocardial infarction
treated with direct angioplasty. Am J Cardiol 1998;82:932–7.
13. van’t Hof AW, Liem A, de Boer MJ, et al. Clinical value of 12-lead
electrocardiogram after successful reperfusion therapy for acute myo-
cardial infarction. Zwolle Myocardial Infarction Study Group. Lancet
1997;350:615–9.
14. Schro¨der R, Dissmann R, Bru¨ggemann T. Extent of early ST segment
elevation resolution: a simple but strong predictor of outcome in
patients with acute myocardial infarction. J Am Coll Cardiol 1994;24:
384–91.
15. Stone GW, Peterson MA, Lansky AJ, et al. Impact of normalized
myocardial perfusion after successful angioplasty in acute myocardial
infarction. J Am Coll Cardiol 2002;39:591–7.
16. Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between
TIMI frame count and clinical outcomes after thrombolytic adminis-
tration. Thrombolysis In Myocardial Infarction (TIMI) Study Group.
Circulation 1999;99:1945–50.
17. Claeys MJ, Bosmans J, Veenstra L, et al. Determinants and prognostic
implications of persistent ST-segment elevation after primary angio-
plasty for acute myocardial infarction: importance of microvascular
reperfusion injury on clinical outcome. Circulation 1999;99:1972–7.
18. Angeja BG, Gunda M, Murphy SA, et al. TIMI myocardial perfusion
grade and ST segment resolution: association with infarct size as
assessed by single photon emission computed tomography imaging.
Circulation 2002;105:282–5.
19. Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein
IIb/IIIa receptor blockade on recovery of coronary flow and left
ventricular function after the placement of coronary-artery stents in
acute myocardial infarction. Circulation 1998;98:2695–701.
20. Gregorini L, Marco J, Kozakova M, et al. Alpha-adrenergic blockade
improves recovery of myocardial perfusion and function after coronary
stenting in patients with acute myocardial infarction. Circulation
1999;99:482–90.
21. Chandra NC, Ziegelstein RC, Rogers WJ, et al. Observations of the
treatment of women in the United States with myocardial infarction.
Arch Intern Med 1998;158:981–8.
22. The GUSTO Investigators. An international randomized trial com-
paring four thrombolytic strategies for acute myocardial infarction.
N Engl J Med 1993;329:673–82.
23. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of the
TIMI myocardial perfusion grades, flow grades, frame count, and
percutaneous coronary intervention to long-term outcomes after
thrombolytic administration in acute myocardial infarction. Circula-
tion 2002;105:1909–13.
538 Haager et al. JACC Vol. 41, No. 4, 2003
Markers of Myocardial Reperfusion February 19, 2003:532–8
